Astragalus Membranaceus Treatment Protects Raw264.7 Cells from Influenza Virus by Regulating G1 Phase and the TLR3-Mediated Signaling Pathway

Table 2

Effects of AMI on the cell cycle of Raw264.7 cells ( ± s·n = 3).

Group	Concentration (mg/ml)	Inhibitory rate (%)	The percentage of cells in each phase (%)
			G1 phase	S phase	G2 phase
Normal control group	0		65.74 ± 2.32	30.89 ± 2.49	3.37 ± 0.17
Virus control group	0		73.14 ± 1.96	22.53 ± 1.91	4.33 ± 0.06
AMI group	9.5	0	76.94 ± 1.02	20.19 ± 0.17	2.87 ± 1.19
	40	10	77.20 ± 0.09	18.81 ± 0.39	3.99 ± 0.48
	92	25	83.87 ± 0.51	13.32 ± 0.51	2.82 ± 0.01
Treatment group	9.5	0	66.60 ± 1.43^##	29.97 ± 1.41^##	3.43 ± 0.02
	40	10	67.58 ± 0.16^##	28.23 ± 0.10^##	4.18 ± 0.06
	92	25	66.68 ± 1.74^##	28.92 ± 2.97^##	4.39 ± 1.24

Note. , compared with the normal control group. , the treatment group compared with the virus control group.